Arch Resources (ARCH)
(Delayed Data from NYSE)
$128.29 USD
+0.02 (0.02%)
Updated Sep 23, 2024 04:00 PM ET
After-Market: $128.31 +0.02 (0.02%) 7:58 PM ET
4-Sell of 5 4
B Value C Growth D Momentum C VGM
Price, Consensus and EPS Surprise
ARCH 128.29 +0.02(0.02%)
Will ARCH be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for ARCH based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for ARCH
New Strong Sell Stocks for September 23rd
New Strong Sell Stocks for September 19th
ARCH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Is the Options Market Predicting a Spike in Arch Resources (ARCH) Stock?
Arch (ARCH), CONSOL to Merge, Focus on Global Coal Market
Zacks Industry Outlook Highlights Peabody Energy, Arch Resources, SunCoke Energy and Ramaco
Other News for ARCH
Arch Resources Inc (ARCH) Trading 3.31% Higher on Sep 12
Warning: ARCH is at high risk of performing badly
Arch Biopartners Announces Alberta Health Services Approval to Proceed with Phase II Trial for LSALT Peptide Targeting Cardiac Surgery-Associated Acute Kidney Injury (CS-AKI)
Alpha Metallurgical Resources: Pullback Offers Opportunity
50 stocks that may see selling pressure as investors begin looking to book tax losses